SCHEMBL23948707

SCHEMBL23948707

c1ccc2c(c1)nc1c3cc4c(cc3c3cccnc3n21)oc1ccccc14

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.40
NPC1 O15118 2/20 0.40
KDM4E B2RXH2 8/20 0.40
HSD17B10 Q99714 4/20 0.40
LMNA P02545 2/20 0.40
POLB P06746 2/20 0.40
TP53 P04637 1/20 0.40
HPGD P15428 7/20 0.39
ALDH1A1 P00352 7/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.36
AHR P35869 1/20 0.35
GAA P10253 2/20 0.35
HIF1A Q16665 1/20 0.35
RAB9A P51151 2/20 0.34
ACHE P22303 1/20 0.34
TSHR P16473 2/20 0.34
MAOA P21397 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21890413 0.89 KDM4E (0.36) MAPTNPC1KDM4EHSD17B10LMNA
SCHEMBL21298174 0.87 HPGD (0.40) MAPTNPC1KDM4EHSD17B10LMNA
SCHEMBL21298167 0.87 HPGD (0.40) MAPTNPC1KDM4EHSD17B10LMNA
SCHEMBL21890315 0.86 KDM4E (0.44) MAPTNPC1KDM4EHSD17B10LMNA
SCHEMBL21890419 0.86 KDM4E (0.44) MAPTNPC1KDM4EHSD17B10LMNA
SCHEMBL24291113 0.82 MAPT (0.40) MAPTNPC1KDM4EHSD17B10LMNA
SCHEMBL24292203 0.82 MAPT (0.40) MAPTNPC1KDM4EHSD17B10LMNA
SCHEMBL21298229 0.82 KDM4E (0.48) MAPTNPC1KDM4EHSD17B10LMNA
SCHEMBL24292194 0.81 KDM4E (0.44) MAPTNPC1KDM4EHSD17B10LMNA
SCHEMBL24292196 0.81 KDM4E (0.44) MAPTNPC1KDM4EHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure TEAD4, TEAD2, TEAD1 MAPT 1313/4885NPC1 4146/4885KDM4E 2817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.